Close Menu

NEW YORK (GenomeWeb) – BioDiscovery announced today that it has signed a collaborative agreement to provide its NxClinical data visualization software to Illumina.

Under the terms of the agreement, NxClinical will be the secondary data analysis and management tool for Illumina's CytoSeq assay. The software will be offered as an interactive tool for visualization and interpretation of genomic events, the firms said, and will directly read CytoSeq results to process data and provide results.

Financial and other details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.